Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-826
Closed -$191K 851
2022
Q1
$191K Sell
826
-136
-14% -$32K 0.05% 342
2021
Q4
$249K Buy
+962
New +$231K 0.06% 299
2020
Q2
Sell
-6,732
Closed -$816K 709
2020
Q1
$816K Sell
6,732
-3,039
-31% -$428K 0.23% 89
2019
Q4
$1.55M Buy
9,771
+4,605
+89% +$710K 0.29% 90
2019
Q3
$752K Buy
5,166
+2,704
+110% +$436K 0.13% 122
2019
Q2
$404K Buy
2,462
+944
+62% +$165K 0.07% 191
2019
Q1
$275K Buy
1,518
+309
+26% +$54.6K 0.05% 192
2018
Q4
$195K Sell
1,209
-150
-11% -$31.7K 0.04% 247
2018
Q3
$326K Sell
1,359
-742
-35% -$180K 0.06% 192
2018
Q2
$481K Buy
+2,101
New +$520K 0.08% 186
2016
Q2
Sell
-1
Closed -$163 585
2016
Q1
$163 Hold
1
﹤0.01% 509
2015
Q4
$149 Hold
1
﹤0.01% 442
2015
Q3
$144 Buy
+1
New +$160 ﹤0.01% 473
2015
Q1
Sell
-70,198
Closed -$12.2M 534
2014
Q4
$12.2M Buy
+70,198
New +$11.9M 1.69% 33

Other funds holding FDX

Exane Derivatives's FDX Position: Q2 2022 in Review

Exane Derivatives sold out of FedEx (FDX) in Q2 2022, closing a stake of 826 shares — an estimated $191K sold.

Exane Derivatives first reported a position in FDX in Q4 2014 and held it in 14 quarters. The position peaked at $12.2M in Q4 2014. 1,645 funds tracked by Wall St. Rank hold FDX as of Q2 2022.

  • Exane Derivatives reported no remaining FedEx position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 826 FedEx shares in Q2 2022, an estimated $191K.
  • Exane Derivatives first reported a position in FedEx in Q4 2014 and held it in 14 quarters.
  • Exane Derivatives's FedEx position peaked at $12.2M in Q4 2014.
  • 1,645 funds tracked by Wall St. Rank held FedEx as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.